IMMUCELL CORP /DE/ (ICCC) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
ICCC currently has 9.05M outstanding shares. with limited dilution risk as only 833K additional shares (9.2%) are authorized for issuance. The company has diluted shareholders by 15.48% over the past 2 years through share issuances.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 14, 2026 |
10-Q filing | 9.0M shares outstanding |
9M | 830K |
| Mar 30, 2026 |
10-K filing | 9.0M shares outstanding |
9M | 850K |
| Nov 13, 2025 |
10-Q filing | 9.0M shares outstanding |
9M | 830K |
| Aug 14, 2025 |
10-Q filing | 9.0M shares outstanding |
9M | 850K |
| May 14, 2025 |
10-Q filing | 9.0M shares outstanding |
9M | 900K |
| Mar 28, 2025 |
10-K filing | 8.2M shares outstanding |
8.2M | 1.7M |
| Nov 13, 2024 |
10-Q filing | 8.2M shares outstanding |
8.2M | 1.7M |
| Aug 13, 2024 |
10-Q filing | 7.8M shares outstanding |
7.8M | 2.1M |
| May 14, 2024 |
10-Q filing | 7.8M shares outstanding |
7.8M | 2.1M |
| Apr 01, 2024 |
10-K filing | 7.7M shares outstanding |
7.7M | 2.1M |
| Apr 01, 2024 |
S-3 filing: The filing is for a shelf offering of common stock, warrants and subscription rights, with a proposed amount of up to $20,000,000.00. It also covers an at-the-market offering of common stock up to $11,000,000. |
7.8M | 2.1M |
| Nov 13, 2023 |
10-Q filing | 7.7M shares outstanding |
7.7M | 0 |
| Aug 10, 2023 |
10-Q filing | 7.7M shares outstanding |
7.7M | 0 |
| May 11, 2023 |
10-Q filing | 7.7M shares outstanding |
7.7M | 0 |
| Mar 29, 2023 |
10-K filing | 7.7M shares outstanding |
7.7M | 0 |
| Nov 21, 2022 |
10-Q filing | 7.7M shares outstanding |
7.7M | 0 |
| Aug 11, 2022 |
10-Q filing | 7.7M shares outstanding |
7.7M | 0 |
| May 12, 2022 |
10-Q filing | 7.7M shares outstanding |
7.7M | 0 |
| Mar 30, 2022 |
10-K filing | 7.6M shares outstanding |
7.6M | 0 |
| Nov 15, 2021 |
10-Q filing | 7.7M shares outstanding |
7.7M | 0 |
| Aug 12, 2021 |
10-Q filing | 7.8M shares outstanding |
7.8M | 0 |
| May 13, 2021 |
10-Q filing | 7.2M shares outstanding |
7.2M | 0 |
| Apr 15, 2021 |
8-K filing: ImmuCell Corporation entered into a Securities Purchase Agreement to issue 515,156 shares of common stock for gross proceeds of $4,250,037 at a price of $8.25 per share. ($4.25M proceeds) |
6.8M | 0 |
| Mar 30, 2021 |
10-K filing | 6.8M shares outstanding |
6.8M | 0 |
| Nov 12, 2020 |
10-Q filing | 7.2M shares outstanding |
7.2M | 0 |
| Aug 12, 2020 |
10-Q filing | 7.2M shares outstanding |
7.2M | 0 |
| May 13, 2020 |
10-Q filing | 7.2M shares outstanding |
7.2M | 0 |
| Mar 27, 2020 |
10-K filing | 6.8M shares outstanding |
6.8M | 0 |